Search research articles
Contact Us
Filters
Showing results (101-110 of 125) with videos related to
Page
of 13
Sort By:
British Journal of Pharmacology
|
April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Journal of Medicinal Chemistry
|
December 20, 2021
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior
Thuy Nguyen, Thomas F Gamage, David B Finlay, et al.
Pharmacology Research & Perspectives
|
January 18, 2022
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
David B Finlay, Thuy Nguyen, Thomas F Gamage, et al.
ACS Chemical Neuroscience
|
July 16, 2016
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Samuel D Banister, Mitchell Longworth, Richard Kevin, et al.
Lipids
|
November 9, 2021
Neuroprotective activity of new Δ3-N-acylethanolamines in a focal ischemia stroke model
Rahau S Shirazi, Mikhail Vyssotski, Kirill Lagutin, et al.
Drug Testing and Analysis
|
October 10, 2019
Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018
Rui Shen Ong, Diana C Kappatos, Sarah G G Russell, et al.
Neurobiology of Disease
|
September 26, 2020
Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains
Pritika Narayan, Suzanne Reid, Emma L Scotter, et al.
ACS Chemical Neuroscience
|
October 15, 2020
Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA
Adam Ametovski, Christa Macdonald, Jamie J Manning, et al.
ACS Chemical Neuroscience
|
April 5, 2013
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse
Samuel D Banister, Shane M Wilkinson, Mitchell Longworth, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 125) with videos related to
Sort By:
Page
of 13
British Journal of Pharmacology
|
April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Journal of Medicinal Chemistry
|
December 20, 2021
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior
Thuy Nguyen, Thomas F Gamage, David B Finlay, et al.
Pharmacology Research & Perspectives
|
January 18, 2022
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
David B Finlay, Thuy Nguyen, Thomas F Gamage, et al.
ACS Chemical Neuroscience
|
July 16, 2016
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Samuel D Banister, Mitchell Longworth, Richard Kevin, et al.
Lipids
|
November 9, 2021
Neuroprotective activity of new Δ3-N-acylethanolamines in a focal ischemia stroke model
Rahau S Shirazi, Mikhail Vyssotski, Kirill Lagutin, et al.
Drug Testing and Analysis
|
October 10, 2019
Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018
Rui Shen Ong, Diana C Kappatos, Sarah G G Russell, et al.
Neurobiology of Disease
|
September 26, 2020
Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains
Pritika Narayan, Suzanne Reid, Emma L Scotter, et al.
ACS Chemical Neuroscience
|
October 15, 2020
Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA
Adam Ametovski, Christa Macdonald, Jamie J Manning, et al.
ACS Chemical Neuroscience
|
April 5, 2013
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse
Samuel D Banister, Shane M Wilkinson, Mitchell Longworth, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Page
of 13